Varlilumab is a monoclonal antibody intended for immunotherapy of solid tumors and hematologic malignancies, used in trials for melanoma, skin ulcers, Burkitt's lymphoma, and other T-cell malignancies. The DrugMonitor™ Anti-Varlilumab Antibody (VS-1224-YC1278) is an anti-drug antibody (ADA) against Varlilumab. This drug-based antibody is raised in mice immunized with the Varlilumab. The anti-Varlilumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Varlilumab in samples.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Afuco™ Anti-CD27 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-H74)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human antibody to Human CD27. It is an immunotherapy designed to enhance the body's natural immune response by directly activating T cells that can specifically recognize and kill cancer cells.
There are currently no Customer reviews or questions for VS-1224-YC1278. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.